BDBM236529 2-Cyclohexylmethyloxy-10-[(2-N,N-dimethylamino-2-methyl)ethyl]benzo[d] isothiazolo[3,2-a]indol-S,S-dioxide (20)
SMILES: CC(CC1=C2C(c3ccc(OCC4CCCCC4)cc13)S(=O)(=O)c1ccccc21)N(C)C
InChI Key: InChIKey=RLDZYTBAMQXYOE-UHFFFAOYSA-N
Data: 1 KI
Target/Host (Institution) | Ligand | Target/Host Links | Ligand Links | Trg + Lig Links | Ki nM | ΔG° kcal/mole | IC50 nM | Kd nM | EC50/IC50 nM | koff s-1 | kon M-1s-1 | pH | Temp °C |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
5-hydroxytryptamine receptor 6 (Homo sapiens (Human)) | BDBM236529 (2-Cyclohexylmethyloxy-10-[(2-N,N-dimethylamino-2-m...) | Reactome pathway KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | Article PubMed | >1.00E+3 | >-8.51 | n/a | n/a | n/a | n/a | n/a | 7.4 | 37 |
Suven Life Sciences Ltd. | Assay Description In brief, receptor source and radioligand used were human recombinant expressed in HEK-293 cells and [3H] LSD (60-80 Ci/mmol), respectively. The fina... | J Enzyme Inhib Med Chem 27: 443-50 (2012) Article DOI: 10.3109/14756366.2011.595713 BindingDB Entry DOI: 10.7270/Q2HD7TJ5 | |||||||||||
More data for this Ligand-Target Pair |